CITRUCEL
-
methylcellulose (4000 cps) tablet
GlaxoSmithKline Consumer Healtcare LP
----------
Drug FactsMethylcellulose (a non-allergenic fiber) 500mg
Bulk-forming laxative
Choking: taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.
These could be signs of a serious condition.
In case of overdose, get medical help or contact a Poison Control Center right away.
TAKE THIS PRODUCT (CHILD OR ADULT DOSE) WITH AT LEAST 8 OUNCES (A FULL GLASS) OF WATER OR OTHER FLUID. TAKING THIS PRODUCT WITHOUT ENOUGH LIQUID MAY CAUSE CHOKING. SEE CHOKING WARNING.
Age | Dose | Maximum Dose |
adults & children 12 years of age and over | start with 2 caplets. Increase as needed up to 6 times per day. | do not exceed 12 caplets per day |
children 6 - 11 years of age | start with 1 caplet. Increase as needed up to 6 times per day. | do not exceed 6 caplets per day |
children under 6 years of age | consult a physician | consult a physician |
crospovidone, dibasic calcium phosphate, FD&C yellow no. 6 aluminum lake, magnesium stearate, maltodextrin, povidone, sodium lauryl sulfate
call toll-free 1-800-897-6081 (English/Spanish) weekdays
TAMPER EVIDENT PACKAGE
BOTTLE SEALED WITH PRINTED FOIL UNDER CAP.
DO NOT USE IF FOIL IS MISSING OR BROKEN.
Patent Nos. 6350469, 7125562, 6372253, 7132114. 62013XD
Distributed by:
GlaxoSmithKline
Moon Twp, PA 15108
©2009 GlaxoSmithKline
CITRUCEL®
METHYLCELLULOSE FIBER THERAPY FOR REGULARITY
with smartfiber®
The Only Fiber for Regularity
That Won’t Cause Excess Gas*
*Based on laboratory testing. Individual results may vary.
Caplets
100 FIBER CAPLETS
BETTER VALUE Per Dose than leading competition
CITRUCEL
methylcellulose tablet |
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part334 | 02/01/2010 |
Labeler - GlaxoSmithKline Consumer Healtcare LP (828924212) |